MCM2 and colorectal carcinoma: Through the analysis of multiple TCGA datasets, ACSL6, AUNIP, CXCL3, CXCL8, CXCL11, EPHX4, GPR143, LRRC8, MAD2L1, MCM2, MELK, MMP3, and NFE2L3 were identified as potential therapeutic biomarkers for CRC.